Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial
Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial
Kazuyoshi Yamamoto, Tomomi Yamada, Kotaro Yamashita, Yusuke Akamaru et al.
Citations
2 citations
Journal
EClinicalMedicine
Topics
Nutrition and Health in Aging
Field-Weighted Citation Impact (FWCI)
2.33
article
Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial
Osaka Gakuin University (JP), Osaka Prefectural Medical Center (JP), Toyonaka Municipal Hospital (JP), Osaka National Hospital (JP), Osaka City General Hospital (JP), Sakai Municipal Hospital (JP), Osaka Rosai Hospital (JP), Kansai Rosai Hospital (JP), Osaka International Cancer Institute (JP), Osaka University Hospital (JP), Nara Institute of Science and Technology (JP), Kindai University (JP), The University of Osaka (JP)